News Briefs

Premium
Hebrew U Spinout Jexys Inks R&D Pact with Teva
 
Yissum, the technology transfer company of the Hebrew University of Jerusalem, said this week that its subsidiary Jexys Pharmaceuticals has inked a strategic R&D agreement with Teva Pharmaceuticals.
 
Under the terms of the agreement, Teva will finance Jexys' development of a high-throughput, yeast-based drug-discovery platform and in return will receive a minority equity interest in Jexys.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

New results from the NASA Twins Study indicate that the immune system may rev up when in space, the Washington Post reports.

Kelvin Droegemeier, the new science advisor, spoke at the American Association for the Advancement of Science meeting, Geekwire reports.

In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.